Petra Lutterbuese

Therapeutic Window of MuS110, a Single-Chain Antibody Construct Bispecific for Murine EpCAM and Murine CD3

Maria Amann, Klaus Brischwein, Petra Lutterbuese et al. · Cancer Research · 2008 · 91 citations

Life Sciences, Immunology, Oncology +17

CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas

Michael D. Oberst, Stacy Fuhrmann, Kathy Mulgrew et al. · mAbs · 2014 · 89 citations · Full text

Medicine, Immunology, Oncology +17

Selective Targeting and Potent Control of Tumor Growth Using an EphA2/CD3-Bispecific Single-Chain Antibody Construct

Scott A. Hammond, Ralf Lutterbuese, Shannon Roff et al. · Cancer Research · 2007 · 80 citations · Full text

Pharmacy, Immunology, Oncology +17

Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA

Ralf Lutterbuese, Tobias Raum, Roman Kischel et al. · Journal of Immunotherapy · 2009 · 77 citations

Life Sciences, Immunology, Oncology +17

Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans

Maria Amann, Matthias Friedrich, Petra Lutterbuese et al. · Cancer Immunology Immunotherapy · 2008 · 40 citations · Full text

Life Sciences, Cell Biology, Immunology +10